Summary:
- The article explores the potential repurposing of mRNA vaccine technology, originally developed for COVID-19, to create personalized therapeutic cancer vaccines.
- It discusses how researchers are leveraging the body's immune response to identify and target specific tumor antigens, offering a promising new frontier in oncology and immunotherapy.